Quick answer: latest quarter results, by ticker or company name

Reported Q: Q3 2024 Rev YoY: +0.3% EPS YoY: -138.1% Move: +4.64%

Ascend Wellness Holdings

AAWH

$0.544 4.64%

Exchange OTC Sector Healthcare Industry Drug Manufacturers Specialty Generic

Q3 2024

Published: Nov 12, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for AAWH

Reported

Report Date

Nov 12, 2024

Quarter Q3 2024

Revenue

141.65M

YoY: +0.3%

EPS

-0.13

YoY: -138.1%

Market Move

+4.64%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $141.65M up 0.3% year-over-year
EPS of $-0.13 decreased by 138.1% from previous year
Gross margin of 30.9%
Net income of -28.26M
""We launched a series of cost savings initiatives and are committed to reducing expenditures by $30 million in 2025."" - Samuel Brill

AAWH

Company AAWH

Period Q3 2024

Currency USD

Report Type Quarterly Earnings

Generated Mar 7, 2026

Swipe to view all report sections

Executive Summary

Ascend Wellness Holdings reported Q3 2024 net revenue of $141.6 million, a modest YoY increase of 0.3% and a QoQ gain of 0.1%. The quarter showcased ongoing operational discipline and a strategic shift toward margin improvement and vertical integration, but the business remained EBITDA-positive yet bottom-line negative due to non-operational items and cost pressures. Management signaled a deliberate cost-reduction program targeting $30 million in annualized savings for 2025, aiming to bridge the current margin gap relative to MSO peers and to drive higher internal demand for Ascend-branded products through densification and a broader retail footprint.

Key Performance Indicators

Revenue

Increasing

141.65M

QoQ: 0.08% | YoY: 0.27%

Gross Profit

Increasing

43.73M

30.87% margin

QoQ: 5.19% | YoY: 0.40%

Operating Income

Decreasing

-2.42M

QoQ: -58.80% | YoY: -168.14%

Net Income

Decreasing

-28.26M

QoQ: -29.71% | YoY: -151.39%

EPS

Decreasing

-0.13

QoQ: -30.00% | YoY: -138.10%

Revenue Trend

Margin Analysis

Financial Highlights

Revenue: $141.647 million for Q3 2024, up 0.27% YoY and up 0.08% QoQ. Gross Profit: $43.729 million; Gross Margin: 30.87% (0.3087). Operating Income: -$2.417 million; Operating Margin: -1.71%. EBITDA: $9.631 million; EBITDARatio: 6.80%. Net Income: -$28.256 million; Net Margin: -19.95%. EPS: -$0.13. Cash Flow: operating cash flow $1.972 million; Free Cash Flow: -$9.45 million. Balance Sheet: Cash $65.28 million; Net Debt $513.16 million; Total Debt $578.44 million; Total Assets $895.87 million; Liabilities $806.96 million; Equity $88.09 million. Coverage and liquidity metrics indicate leverage remains a key concern despite sequential cash flow generation.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	141.65M	0.27%	0.08%
Gross Profit	43.73M	0.40%	5.19%
Operating Income	-2.42M	-168.14%	-58.80%
Net Income	-28.26M	-151.39%	-29.71%
EPS	-0.13	-138.10%	-30.00%

Key Financial Ratios

Gross Profit Margin

Fair

30.90%

Gross profit margin is moderate, room for improvement in cost management

Operating Profit Margin

Weak

-0.02%

Operating margin is below industry norms, profitability concerns

Net Profit Margin

Weak

-0.20%

Net profit margin is below industry norms, profitability concerns

Return on Assets

Weak

-0.03%

Return on assets suggests inefficient capital allocation

Return on Equity

Weak

-0.32%

Return on equity suggests inefficient capital allocation

Current Ratio

Adequate

1.47

Current ratio meets minimum requirements but limited cushion

Debt to Equity

High Risk

6.57

Debt-to-equity indicates high leverage and elevated financial risk

P/E Ratio

Negative

-1.60x

Negative earnings make P/E ratio not meaningful

Price to Book

Fair Value

2.05x

Price-to-book ratio reasonable for profitable companies

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q3 2025	124.73	-0.13	-11.9%	View
Q2 2025	127.30	-0.12	-10.1%	View
Q1 2025	128.00	-0.09	-10.1%	View
Q4 2024	136.01	-0.08	-3.0%	View
Q3 2024	141.65	-0.13	+0.3%	View

AAWH

Ascend Wellness Holdings

Q3 2025 Report

Ascend Wellness Holdings Inc (AAWH) Q3 2025 Results – Margin Expansion Amid Slower Top-Line Growth Driven by Densification, Brand Portfolio and Digi...

Read full report

AAWH

Ascend Wellness Holdings

Q2 2025 Report

Ascend Wellness Holdings Inc (AAWH) QQ2 2025 Earnings Analysis: Margin Expansion, Retail Densification, and Strategic Positioning in a Turbulent US Ca...

Read full report

AAWH

Ascend Wellness Holdings

Q1 2025 Report

Ascend Wellness Holdings Inc (AAWH) Q1 2025 Results Analysis: Densification and CPG Push Amid Price Compression in Healthcare Cannabis...

Read full report

AAWH

Ascend Wellness Holdings

Q4 2024 Report

Ascend Wellness Holdings Inc (AAWH) QQ4 2024 Earnings Review: Profitability Turnaround, Densification Strategy and Margin Expansion in a Price-Compres...

Read full report

Ascend Wellness Holdings (AAWH) Q3 2024 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Historical Earnings Comparison

More AAWH Quarterly Reports

AAWH

AAWH

AAWH

AAWH

Q3 2024 Reports in Healthcare Sector

Related Financial Data

Sector Analysis: Healthcare

AAWH Full Profile

AAWH Financial Statements

Earnings Calendar